Growth Metrics

Eli Lilly (LLY) Dividends Paid - Common (2016 - 2026)

Eli Lilly filings provide 18 years of Dividends Paid - Common readings, the most recent being $1.5 billion for Q1 2026.

  • On a quarterly basis, Dividends Paid - Common rose 15.01% to $1.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $5.6 billion, a 15.01% increase, with the full-year FY2025 number at $5.4 billion, up 15.04% from a year prior.
  • Dividends Paid - Common hit $1.5 billion in Q1 2026 for Eli Lilly, up from $1.3 billion in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $2.0 billion in Q2 2023 to a low of $882.2 million in Q3 2022.
  • Median Dividends Paid - Common over the past 5 years was $1.2 billion (2024), compared with a mean of $1.2 billion.
  • Biggest five-year swings in Dividends Paid - Common: plummeted 42.36% in 2024 and later grew 15.21% in 2025.
  • Eli Lilly's Dividends Paid - Common stood at $884.4 million in 2022, then grew by 15.08% to $1.0 billion in 2023, then grew by 14.75% to $1.2 billion in 2024, then grew by 15.21% to $1.3 billion in 2025, then increased by 15.05% to $1.5 billion in 2026.
  • The last three reported values for Dividends Paid - Common were $1.5 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025) per Business Quant data.